Tag Archives: takes

Pfizer, Merck KGaA's Bavencio takes a hit with second ovarian cancer failure

Back in November, Pfizer and Merck KGaA reported that immuno-oncology drug Bavencio had failed a late-stage ovarian cancer trial. And now the companies can make it two. Friday, the partners said they’d scrapped a phase 3 study examining Bavencio in combination with and/or after chemo in previously untreated patients after the drug showed it couldn’t… Read More »

Acne Studios Takes Minority Investment | Breaking News, News & Analysis – The Business of Fashion

STOCKHOLM, Sweden — Acne Studios has sold minority stakes to China-focused investment firm IDG Capital and Hong Kong-based I.T Group, ending almost a year of speculation that the brand would be acquired by a larger rival. Acne, one of the earliest and most successful purveyors of the “Scandinavian cool” style that has since become popular… Read More »